Ironwood Pharmaceuticals
1998
FOUNDED
PUBLIC
STATUS
501-600
EMPLOYEES
IRWD
STOCK SYMBOL
$12.53
SHARE PRICE
(As of Tuesday Closing)
Description
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NAS
Primary Office
- 301 Binney Street
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ironwood Pharmaceuticals’s full profile, request a free trial.
Ironwood Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $7.91 - $14.10 | $1.96B | $12.60 | -$0.27 | 1.72M | 157M |
Ironwood Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,676,718 | 1,843,962 | 2,415,765 | 2,290,617 |
| Revenue | 432,804 | 346,639 | 298,276 | 273,957 |
| EBITDA | (25,173) | (233,412) | (68,061) | (32,464) |
| Net Income | (41,846) | (282,368) | (116,937) | (81,708) |
| Total Assets | 334,343 | 332,050 | 605,674 | 709,821 |
| Total Debt | 435,269 | 413,923 | 400,168 | 372,801 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Ironwood Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Ironwood Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookIronwood Pharmaceuticals Competitors (23)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Samumed | Private Equity-Backed | San Diego, CA | 000 | 00000 | 0000000 0000 | 00000 |
| 000000 | Formerly VC-backed | San Diego, CA | 00 | 000000&0 | ||
| 000000000 000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
| 00000000 00000 | Formerly VC-backed | Leiden, Netherlands | 000 | 00000 | 000000000 | 00000 |
| 000000 000000000 | Formerly Angel backed | Brooklyn, NY | 00 | 00.000 | 00000000 | 00.000 |
Ironwood Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Ironwood Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookIronwood Pharmaceuticals Executive Team (21)
4 Former Executives
You’re viewing 5 of 21 executives. Get the full list »Ironwood Pharmaceuticals Board Members (14)
6 Former Board Members
You’re viewing 5 of 14 board members. Get the full list »